Please login to the form below

Not currently logged in
Email:
Password:

ABPI updates phase 1 clinical trial guidelines

UK pharma industry body issues first new version of guidance since 2007

Guidelines for phase 1 clinical trials (2012 edition)

The Association of the British Pharmaceutical Industry (ABPI) has updated its early-stage trial guidance for the UK pharma industry.

The new version of the Guidelines for Phase 1 Clinical Trials, the first since a major revision in 2007, was created to take account of a number of regulatory changes and ensure they remain relevant for the future.

Stephen Whitehead, chief executive of the ABPI, said: “Ten to twenty years from now there will be a whole raft of innovative new medicines saving and improving patients' lives as a result of the experimental research taking place today.

“In phase 1 research, which represents the link between scientific research and clinical medicine, the highest possible level of knowledge, standards and skills must all be brought together.

“The ABPI has produced these guidelines to help support and simplify the critical role of phase 1 research, while helping researchers ensure their work is conducted with the highest possible level of efficacy and safety.”

Most of changes to the Guidelines stem from the introduction of Good Clinical Practice (GCP), Good Manufacturing Practice (GMP) and the Clinical Trials Directive, which is based on GCP and GMP.

The Guidelines also have a section on pharmacovigilance, which has this year undergone its biggest changes in seven years as a result of new European legislation.

However, another new version of the Guidelines may soon be needed. The EMA last month published proposals for simplifying clinical trial rules and cutting down on red tape. 

• The Guidelines for Phase 1 Clinical Trials can be downloaded from the ABPI website

15th August 2012

Share

Related Hub content

    Your search did not contain any words. Please try again.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
KnowledgePoint360 Group

KnowledgePoint360's medical communications expertise helps healthcare providers improve patient care, and helps pharma and biotech companies inform clinicians about important...

Latest intelligence

Online Physician Communities
M3 improves personalisation of pharma engagement with doctors
Launches new messaging service on Doctors.net.uk...
Digital Futures 2014 slide deck
Full slides, including survey data, from PMLiVE's digital pharma marketing online event...
The Chinese diabetes challenge
Marketing, communications and commercial relationships in China are full of pitfalls for the unwary, but not without great potential ...